Canale 5 TG5 – 14 Aprile 2020
TG 5 PRESENTER
Meanwhile, progress on treatment is (also) being made: the end of April sees the starts of human trials of a new vaccine which has been developed by a company in Pomezia together with Oxford University
The search for a vaccine against Covid-19 moves forward apce; one of the fastest in the trial process is the Jenner Institute at Oxford University in the UK, which will begin accelerated trials on humans in England at the end of April and is already looking for 550 healthy volunteers.
The vaccine is being produced in collaboration with a company in Pomezia: Advent IRBM, which will initially produce 1.000 doses for the first clinical trials.
PIERO DI LORENZO
The Jenner Institute has been working on Coronaviruses and has been researching them, with significant financial investment, for 17 years. We developed our expertise with the anti-Ebola vaccine 7 years ago and so we are more than up to the task.
If human trials are successful, the vaccination of British police and national health workers could begin as early as September.
This vaccine uses a platform which has already been used for the Ebola vaccine, the advantage here would be in being able to speed up the timescales.
There are dozens of public and private laboratories working on a vaccine. Professor Rezza stresses that, in times of emergency, regulatory agencies are more generous and speed up the timescales weighing up the risks and advantages of faster testing always on the understanding that going into entire world population, with billions of doses, will take many more months.
PIERO DI LORENZO
When an emergency arises, everyone immediately asks: “When will the vaccine be ready?” “ When wil the treatment be ready?” We need to remember that these studies should be funded when there is no emergency. Once the emergency is here, time has already run out.[/vc_column_text][/vc_column][/vc_row]